All stock lists
Ceribell, Inc. (NASDAQ:CBLL)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
27.03-0.10 (-0.37%)
Insider Score
––Not scored
CBLL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CBLL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 28.10 M | 26.49 M | 24.78 M | 22.59 M | 21.20 M | 20.49 M |
| Revenue Growth (YoY) | 32.54 % | 29.30 % | 33.72 % | 31.37 % | 42.68 % | 37.92 % |
| Cost of Revenue | 2.16 M | 3.37 M | 3.14 M | 2.65 M | 2.52 M | 2.48 M |
| Gross Profit | 25.94 M | 23.12 M | 21.64 M | 19.94 M | 18.68 M | 18.01 M |
| SG&A Expense | 39.17 M | 37.71 M | 31.18 M | 29.61 M | 28.78 M | 27.97 M |
| R&D Expense | 6.75 M | 6.16 M | 5.06 M | 4.98 M | 4.85 M | 4.25 M |
| Operating Expenses | 45.92 M | 43.87 M | 36.24 M | 34.59 M | 33.63 M | 32.21 M |
| Operating Income | -19.98 M | -20.75 M | -14.60 M | -14.65 M | -14.95 M | -14.21 M |
| Pretax Income | -19.27 M | -19.74 M | -13.53 M | -13.46 M | -13.64 M | -12.78 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -19.27 M | -19.74 M | -13.53 M | -13.46 M | -13.64 M | -12.78 M |
| EPS (Basic) | -0.51 | -0.52 | -0.36 | -0.37 | -0.38 | -0.36 |
| EPS (Diluted) | -0.51 | -0.52 | -0.36 | -0.37 | -0.38 | -0.36 |
| Shares Outstanding | 38.03 M | 37.66 M | 37.22 M | 36.81 M | 36.29 M | 35.88 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.